NCT01997411 - Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

Nasal Glucagon

DRUG

Intramuscular Glucagon

Trial Locations (7)

UPA Buffalo, Buffalo

Nemours Children's Clinic, Jacksonville

University of Florida, Gainesville

Riley Hospital for Children Indiana University Health, Indianapolis

University of Minnesota, Minneapolis

Barbara Davis Center for Diabetes, Aurora

Yale University, New Haven